Synthesis-to-screen process for drug discovery

The automated flow chemistry and biology platform can rapidly synthesise molecules and screen them as potential drugs.

It is designed to significantly accelerate the drug-discovery process, by giving researchers a platform to synthesise and test a greater range of potential new medicines in a considerably shorter time frame.

It is envisaged that this technology will radically transform drug discovery by improving both the efficiency and the overall cost to the industry.

Cyclofluidic has successfully demonstrated this fully integrated approach encompassing chemical synthesis of a pharmaceutically relevant molecule through to the generation of high-quality target-screening data.